Related Experiment Video
Updated: Feb 28, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Cardiac fibroblast transcriptome analyses support a role for interferogenic, profibrotic, and inflammatory genes in
Robert M Clancy1, Androo J Markham2, Tanisha Jackson2
1Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, New York robert.clancy@nyumc.org.
Insights
Maternal anti-Ro autoantibodies cause congenital heart block (CHB) by triggering Type I Interferon (IFN) responses in fetal heart fibroblasts. This leads to abnormal cardiac remodeling and fibrosis, contributing to CHB development.
Area of Science:
- Cardiovascular Research
- Immunology
- Developmental Biology
Background:
- Congenital heart block (CHB) is associated with SSA/Ro autoantibodies, characterized by cardiac fibrosis and macrophage infiltration.
- Understanding the role of fibroblasts in CHB pathogenesis is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the molecular mechanisms underlying fibroblast activation and cardiac fibrosis in SSA/Ro autoantibody-associated CHB.
- To compare the transcriptomes of fetal cardiac fibroblasts in CHB and healthy hearts.
Main Methods:
- In vitro simulation of cardiac injury using human fetal cardiac fibroblasts exposed to macrophage supernatants.
- Transcriptome analysis of stimulated fibroblasts and fibroblasts isolated from fetal hearts with and without CHB.
- Bioinformatic analysis (e.g., Database for Annotation, Visualization and Integrated Discovery) to identify differentially expressed genes.
Main Results:
- Stimulated fibroblasts exhibited upregulated Type I Interferon (IFN) response genes and altered expression of fibrotic pathway genes.
- In vivo analysis of CHB fetal hearts revealed upregulation of IFN response genes and matrix-related genes in fibroblasts.
- ERK5 signaling pathway was implicated in the fibroblast response to injury.
Conclusions:
- Upregulation of Type I IFN response genes in fetal cardiac fibroblasts contributes to abnormal cardiac remodeling and fibrosis in CHB.
- This study provides novel in vitro and in vivo evidence supporting the role of Type I IFN in CHB pathogenesis.
Abstract:
The signature lesion of SSA/Ro autoantibody-associated congenital heart block (CHB) is fibrosis and a macrophage infiltrate, supporting an experimental focus on cues influencing the fibroblast component. The transcriptomes of human fetal cardiac fibroblasts were analyzed using two complementary approaches. Cardiac injury conditions were simulated in vitro by incubating human fetal cardiac fibroblasts with supernatants from macrophages transfected with the SSA/Ro-associated noncoding Y ssRNA. The top 10 upregulated transcripts in the stimulated fibroblasts reflected a type I interferon (IFN) response [e.g., IFN-induced protein 44-like (IFI44L), of MX dynamin-like GTPase (MX)1, MX2, and radical S-adenosyl methionine domain containing 2 (Rsad2)]. Within the fibrotic pathway, transcript levels of endothelin-1 (EDN1), phosphodiesterase (PDE)4D, chemokine (C-X-C motif) ligand (CXCL)2, and CXCL3 were upregulated, while others, including adenomedullin, RAP guanine nucleotide exchange factor 3 (RAPGEF3), tissue inhibitor of metalloproteinase (TIMP)1, TIMP3, and dual specificity phosphatase 1, were downregulated. Agnostic Database for Annotation, Visualization and Integrated Discovery analysis revealed a significant increase in inflammatory genes, including complement C3A receptor 1 (C3AR1), F2R-like thrombin/trypsin receptor 3, and neutrophil cytosolic factor 2. In addition, stimulated fibroblasts expressed high levels of phospho-MADS box transcription enhancer factor 2 [a substrate of MAPK5 (ERK5)], which was inhibited by BIX-02189, a specific inhibitor of ERK5. Translation to human disease leveraged an unprecedented opportunity to interrogate the transcriptome of fibroblasts freshly isolated and cell sorted without stimulation from a fetal heart with CHB and a matched healthy heart. Consistent with the in vitro data, five IFN response genes were among the top 10 most highly expressed transcripts in CHB fibroblasts. In addition, the expression of matrix-related genes reflected fibrosis. These data support the novel finding that cardiac injury in CHB may occur secondary to abnormal remodeling due in part to upregulation of type 1 IFN response genes.NEW & NOTEWORTHY Congenital heart block is a rare disease of the fetal heart associated with maternal anti-Ro autoantibodies which can result in death and for survivors, lifelong pacing. This study provides in vivo and in vitro transcriptome-support that injury may be mediated by an effect of Type I Interferon on fetal fibroblasts.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy

